Navigation Links
Arizona Pain Specialists Contend Recent Vertebroplasty Studies are Misleading

SCOTTSDALE, Ariz., Aug. 7 /PRNewswire/ -- Two studies released August 6, 2009 in the New England Journal of Medicine claim to demonstrate that vertebroplasty, a procedure to treat some painful spine fractures, is not effective. According to several authorities in the field, this is incorrect, as both studies actually demonstrate a significant improvement in patients' pain and ability to function normally.

Tory McJunkin, MD, co-founder of Arizona Pain Specialists, has a personal connection because his grandmother recently had the procedure performed with a life-changing, pain-relieving outcome. Dr. McJunkin explained that "Clinical data show that this procedure relieves pain and improves patients' quality of life. I have seen amazing results from vertebroplasty in my practice and for my grandmother."

Allen Burton, MD, Professor of Anesthesiology at MD Anderson in Houston, one of the foremost experts on vertebroplasty, stated, "The conclusion that vertebroplasty does not help back pain is completely wrong. If you look closely at the study design, what they are calling a placebo is actually a facet injection."

"These studies actually show that both treatments are effective," said Paul Lynch, MD, co-founder of Arizona Pain Specialists. "The studies did not use a true control group condition, where patients would receive no treatment. The 'control' patients actually received a different effective treatment and both groups demonstrated highly clinically significant reductions in pain. This demonstrates that vertebroplasty is an effective procedure, although facet injections are also effective."

Pain is often measured on a 0 to 10 scale, with higher numbers indicating greater pain. The studies demonstrate that patients who received the vertebroplasty procedure had reductions in pain of 2.3 and 3.0 points in the two studies, compared to reductions of 1.7 and 2.6 for the facet injection procedure.

Dr. McJunkin said, "Note that patients who received the vertebroplasty procedure had greater reductions in pain, although this was not a statistically significant difference."

To demonstrate statistical differences between groups requires that the study have enough patients for the statistics to have sufficient power to detect the differences. Both studies reported that they were unable to enroll enough patients to have reasonable statistical power. One study noted that they needed 250 patients but only enrolled 131. "The trends in the data demonstrate that if the studies had enough patients, the group receiving vertebroplasty would have had significantly better pain reduction than the other treatment groups," noted Dr. Lynch.

Several large studies have examined and concluded the clinical benefit and efficacy of vertebroplasty for painful vertebral compression fractures. In 2006, Spine Journal released a systematic review of all available data showing 87% relief of pain with vertebroplasty. A 2007 study in the American Journal of Neuroradiology concluded that "Percutaneous Vertebroplasty is a safe and effective method to treat VCF. An immediate improvement in pain is expected for most patients, and disability, mobility, and pain medication use are improved during the short- and long-term periods."

Dr. Lynch agrees with this overall assessment. "Vertebroplasty is only one of several effective treatments, but for some patients it is the best option. These studies, like most studies, have several problems. It would be inappropriate for us to conclude that vertebroplasty is ineffective, as some reports have stated," he concludes.

Arizona Pain Specialists was co-founded by Dr. Paul Lynch and Dr. Tory McJunkin in Scottsdale, AZ. The clinic utilizes a comprehensive model including cutting-edge interventional pain treatments, chiropractic, biofeedback, relaxation therapy and features on-site physio-rehab, an open MRI, procedure center and research department. The clinic's website, hosts an online textbook resource and receives more than 35,000 views a month.

SOURCE Arizona Pain Specialists
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. The University of Arizona College of Medicine and OmegaGenesis Announce Collaboration Agreement to Address Diabetic Foot Ulcers
2. Arizona Heart Innovative Technologies Licenses New Endovascular Device
3. Arizona Heart Institute First to Implant Powerlink XL in Phoenix, Arizona Since FDA Approval
4. First Annual Arizona Biotech Day Announced for October 23rd 2008
5. ThirdBiotech Launches Research Institute to Promote Formation and Growth of Arizona-Based Biotech Companies
6. Arizona-Based SenesTech, Inc., Partners With Australia to Stop Starvation Due to Rice Shortages
7. VAP Cholesterol Test From Atherotech Covers 90 Percent of Arizona Insured
8. Arizona Pain Society and Dr. Robert Barkin, Rush University Medical Center, Present Program on Comprehensive Urine Drug Testing Sponsored by Dominion Diagnostics
9. Helix Biopharma announces addition of University of Arizona professor Kenneth Hatch as new medical advisor
10. West Penn Allegheny Health System Announces Recruitment of Leading Burn Specialists
11. Unique New Initiative by World-Recognized Specialists in Heart Disease and Diabetes to Reduce Residual Vascular Risk Launched Today
Post Your Comments:
(Date:11/25/2015)... , November 25, 2015 ... Report is a professional and in-depth study on ...      (Logo: ) , ... the industry including definitions, classifications, applications and industry ... for the international markets including development trends, competitive ...
(Date:11/24/2015)... , Nov. 24, 2015 Halozyme Therapeutics, Inc. (NASDAQ: ... in New York on Wednesday, December 2 ... Torley , president and CEO, will provide a corporate overview. ... York at 1:00 p.m. ET/10:00 a.m. PT . ... relations, will provide a corporate overview. --> th ...
(Date:11/24/2015)... -- Clintrax Global, Inc., a worldwide provider of clinical research services headquartered ... the company has set a new quarterly earnings record in Q3 ... posted for Q3 of 2014 to Q3 of 2015.   ... , with the establishment of an Asia-Pacific ... United Kingdom and Mexico , with ...
(Date:11/24/2015)... 2015 --> ... released by Transparency Market Research, the global non-invasive prenatal ... of 17.5% during the period between 2014 and 2022. ... Industry Analysis, Size, Volume, Share, Growth, Trends and Forecast ... market to reach a valuation of US$2.38 bn by ...
Breaking Biology Technology:
(Date:11/9/2015)... 2015 ... "Global Law Enforcement Biometrics Market 2015-2019" ... ) has announced the addition ... Market 2015-2019" report to their offering. ... ) has announced the addition of ...
(Date:11/2/2015)... Calif. , Nov. 2, 2015  SRI International ... million to provide preclinical development services to the National ... contract, SRI will provide scientific expertise, modern testing and ... variety of preclinical pharmacology and toxicology studies to evaluate ... --> The PREVENT Cancer Drug Development Program ...
(Date:10/29/2015)... 2015 Daon, a global leader in mobile ... a new version of its IdentityX Platform , ... America have already installed IdentityX v4.0 and ... FIDO UAF certified server component as an ... FIDO features. These customers include some of the largest ...
Breaking Biology News(10 mins):